IRMD news

Iradimed Corp reported third quarter revenue of $24.2 million, up 18% sequentially, and announced a quarterly dividend of $0.20 per share. The company lifted its full-year revenue guidance and reaffirmed its position to penetrate the MRI monitoring market.

Iradimed announced a $0.20 per share quarterly dividend and affirmed its 2026 revenue and earnings forecasts. The company also reported somewhat flat quarterly revenue due to supply constraints of its new IV pump but noted strong order bookings.

IR-Med, Inc. has issued common stock purchase warrants to investors under a Securities Purchase Agreement dated June 1, 2026. The warrants are exercisable between June 1, 2026 and June 2, 2031 and represent dilution potential for existing shareholders.